Sign inGet started

Milligan Sandra

Insider CIK 1859810 · SYRE Director · GOSS Director · OGN Head of Research & Development · AWH President

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GOSS Gossamer Bio, Inc. A Award deriv2026-09-232026-09-2510,000— $010,000SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2026-09-232026-09-2510,000— $010,000SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2026-06-042026-06-05115,000— $0115,000SEC↗
SYRE Spyre Therapeutics, Inc. A Award deriv2026-05-272026-05-298,026— $08,026SEC↗
GOSS Gossamer Bio, Inc. P Buy2025-08-192025-08-2026,050$1.92 $50.0K58,050SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2025-06-252025-06-26115,000— $0115,000SEC↗
SYRE Spyre Therapeutics, Inc. A Award deriv2025-05-292025-06-0225,000— $025,000SEC↗
AWH Aspira Women's Health Inc. F Tax w/h2025-01-082025-01-296,356$0.70 $4.4K13,644SEC↗
AWH Aspira Women's Health Inc. M Exercise deriv2024-12-312025-01-0820,000— $00SEC↗
AWH Aspira Women's Health Inc. M Exercise deriv2024-12-312025-01-2920,000— $00SEC↗
AWH Aspira Women's Health Inc. M Exercise2024-12-312025-01-0820,000— $020,000SEC↗
AWH Aspira Women's Health Inc. M Exercise2024-12-312025-01-2920,000— $020,000SEC↗
AWH Aspira Women's Health Inc. A Award deriv2024-11-122024-11-1325,000— $025,000SEC↗
AWH Aspira Women's Health Inc. A Award deriv2024-10-282024-10-2820,000— $020,000SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2024-06-062024-06-06115,000— $0115,000SEC↗
SYRE Spyre Therapeutics, Inc. A Award deriv2024-05-142024-05-1621,980— $021,980SEC↗
AWH Aspira Women's Health Inc. A Award deriv2024-05-032024-05-0630,000— $030,000SEC↗
GOSS Gossamer Bio, Inc. P Buy2023-11-152023-11-1732,000$0.79 $25.3K32,000SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2023-06-082023-06-0935,000— $035,000SEC↗
OGN Organon & Co. M Exercise deriv2023-05-042023-05-084,984— $04,984SEC↗
OGN Organon & Co. M Exercise2023-05-042023-05-084,984— $030,767SEC↗
OGN Organon & Co. F Tax w/h2023-05-042023-05-082,168$24.24 $52.6K28,599SEC↗
OGN Organon & Co. M Exercise deriv2023-05-012023-05-031,899— $00SEC↗
OGN Organon & Co. F Tax w/h2023-05-012023-05-03826$24.63 $20.3K25,783SEC↗
OGN Organon & Co. M Exercise2023-05-012023-05-031,899— $026,609SEC↗
OGN Organon & Co. A Award deriv2023-03-312023-04-04104,961— $0104,961SEC↗
OGN Organon & Co. A Award deriv2023-03-312023-04-0429,230— $029,230SEC↗
OGN Organon & Co. M Exercise deriv2023-03-312023-04-045,964— $011,928SEC↗
OGN Organon & Co. M Exercise2023-03-312023-04-045,964— $026,825SEC↗
OGN Organon & Co. F Tax w/h2023-03-312023-04-042,115$23.09 $48.8K24,710SEC↗
OGN Organon & Co. M Exercise deriv2023-02-282023-03-027,976— $00SEC↗
OGN Organon & Co. F Tax w/h2023-02-282023-03-022,346$25.09 $58.9K20,861SEC↗
OGN Organon & Co. M Exercise2023-02-282023-03-027,976— $023,207SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2022-06-092022-07-1530,000— $030,000SEC↗
OGN Organon & Co. M Exercise deriv2022-05-042022-05-054,984— $04,984SEC↗
OGN Organon & Co. M Exercise2022-05-042022-05-054,984— $017,037SEC↗
OGN Organon & Co. F Tax w/h2022-05-042022-05-051,806$32.44 $58.6K15,231SEC↗
OGN Organon & Co. M Exercise deriv2022-05-032022-05-051,842— $01,842SEC↗
OGN Organon & Co. F Tax w/h2022-05-032022-05-05525$32.08 $16.8K12,053SEC↗
OGN Organon & Co. M Exercise2022-05-032022-05-051,842— $012,578SEC↗
OGN Organon & Co. M Exercise deriv2022-05-012022-05-031,896— $01,896SEC↗
OGN Organon & Co. M Exercise2022-05-012022-05-031,896— $011,276SEC↗
OGN Organon & Co. F Tax w/h2022-05-012022-05-03540$32.33 $17.5K10,736SEC↗
OGN Organon & Co. A Award deriv2022-03-312022-04-0455,114— $055,114SEC↗
OGN Organon & Co. A Award deriv2022-03-312022-04-0417,892— $017,892SEC↗
OGN Organon & Co. M Exercise deriv2022-02-282022-03-0210,171— $00SEC↗
OGN Organon & Co. F Tax w/h2022-02-282022-03-022,941$37.57 $110.5K9,380SEC↗
OGN Organon & Co. M Exercise2022-02-282022-03-0210,171— $012,321SEC↗
OGN Organon & Co. A Award deriv2021-08-172021-08-1922,321— $022,321SEC↗
GOSS Gossamer Bio, Inc. A Award deriv2021-06-102021-06-1447,000— $047,000SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-043,795— $03,795SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-041,842— $01,842SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0414,957— $014,957SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0410,170— $010,170SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-047,975— $07,975SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0419,828— $019,828SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0448,931— $048,931SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0463,054— $063,054SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-04115,980— $0115,980SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0444,503— $044,503SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0441,588— $041,588SEC↗
OGN Organon & Co. A Award deriv2021-06-022021-06-0453,919— $053,919SEC↗